Articles tagged with 'VIP' | Bayer

Newsroom Bayer (VIP)

2020
June
17,
2020
| 09:30 AM Europe/Amsterdam
Through its new "Better Farms, Better Lives" initiative, Bayer will complement its current commitment to support smallholder farmers in key countries by donating seeds and crop protection inputs / The donations help boost food security by supporting ...
Read more
March
27,
2020
| 17:15 PM Europe/Amsterdam
Stockholders able to exercise right to submit questions and cast votes in a timely manner / Online stockholders’ meeting enables proposed dividend of 2.80 euros per share for 2019 to be paid on time and in full / Baumann: "Reliability for our stockho...
Read more
2018
November
29,
2018
| 15:15 PM Europe/Amsterdam
Group plans to exit Animal Health business, the Consumer Health brands Coppertone™ and Dr. Scholl’s™, and sell its 60-percent interest in Currenta, a site services provider in Germany / Efficiency and structural measures set to enhance competitivenes...
Read more
November
27,
2018
| 15:30 PM Europe/Amsterdam
The safety and efficacy profile of Jivi has been demonstrated in more than five years of clinical studies / Prophylaxis with Jivi enables sustained factor VIII concentrations in the blood over time...
Read more
November
27,
2018
| 01:45 AM Europe/Amsterdam
First treatment with a tumor-agnostic indication at the time of initial FDA approval / Larotrectinib approved under the brand name Vitrakvi® / 75% overall response rate (ORR) (95% CI, 61%, 85%) [22% complete response (CR) and 53% partial response (PR...
Read more
November
13,
2018
| 07:30 AM Europe/Amsterdam
Group sales increase by 1.9 percent (Fx & portfolio adj.) to 9.905 billion euros / EBITDA before special items level year on year at 2.202 billion euros / Business performance at Pharmaceuticals remains strong / Consumer Health with increase in sales...
Read more
October
24,
2018
| 07:30 AM Europe/Amsterdam
The safety and tolerability observed in the trial were consistent with previously published data on darolutamide...
Read more
October
21,
2018
| 11:12 AM Europe/Amsterdam
Data presented across 122 adult and pediatric patients (55 patients from primary dataset plus supplementary dataset with 67 additional patients) with TRK fusion cancer across various tumor types / Integrated dataset on larotrectinib demonstrated high...
Read more
October
12,
2018
| 09:00 AM Europe/Amsterdam
Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease / Xarelto, in combination with aspirin, is the only non-vitamin K antag...
Read more
September
21,
2018
| 13:45 PM Europe/Amsterdam
The safety and efficacy profile of BAY94-9027 has been demonstrated in more than five years of clinical studies / Prophylaxis with BAY94-9027 enables sustained factor VIII concentrations in the blood over time...
Read more
September
21,
2018
| 09:30 AM Europe/Amsterdam
Berlin, September 21, 2018 - Bayer announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Jivi® (BAY94-9027) for the prophylactic treatment of hemophilia A for adults and adolescents 12 years of age or older in J...
Read more
September
13,
2018
| 12:00 PM Europe/Amsterdam
Dieter Weinand leaving the company as of November 1, 2018 / Contract extensions for Board of Management members Liam Condon and Dr. Hartmut Klusik...
Read more
September
05,
2018
| 07:30 AM Europe/Amsterdam
Monsanto business included on prorated basis from June 7 / Group sales advance by 8.5 percent (Fx & portfolio adj.) to 9.481 billion euros / EBITDA before special items increases by 3.9 percent to 2.335 billion euros despite unfavorable currency effe...
Read more
September
04,
2018
| 14:00 PM Europe/Amsterdam
Ballerup, Denmark / Leverkusen, Germany, September 4, 2018 - LEO Pharma and Bayer announced today the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States....
Read more
September
03,
2018
| 16:30 PM Europe/Amsterdam
Monheim/St. Louis, September 3, 2018 - Bayer welcomes the ruling issued today by a Brazilian court that ensures growers in that country will have continued access to glyphosate-based herbicides. "This ruling is very good news for Brazilian growers, ...
Read more
August
30,
2018
| 13:00 PM Europe/Amsterdam
Jivi’s extended half-life allows for twice-weekly initial dosing / May be adjusted to every five days and further individually adjusted to less or more frequent dosing...
Read more
August
27,
2018
| 11:00 AM Europe/Amsterdam
Studies in very sick patient populations reaffirm and further strengthen the safety profile of rivaroxaban / Study results did not show a statistical difference in primary endpoints / COMMANDER HF study evaluated rivaroxaban in patients following an ...
Read more
August
27,
2018
| 08:30 AM Europe/Amsterdam
Berlin, August 27, 2018 - Bayer announced today that the marketing authorization application (MAA) for larotrectinib has been submitted to the European Medicines Agency (EMA). Larotrectinib was developed to treat adult and pediatric patients with loc...
Read more
August
24,
2018
| 09:30 AM Europe/Amsterdam
Xarelto is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in patients with coronary artery disease or symptomatic peripheral artery di...
Read more
August
20,
2018
| 18:35 PM Europe/Amsterdam
Leverkusen, August 20, 2018 - Upon application by Bayer, the Hamburg Regional Court on August 20, 2018, prohibited last Thursday’s report by German magazine WirtschaftsWoche claiming that Bayer faces "new trouble" because of further lawsuits against ...
Read more
August
17,
2018
| 17:30 PM Europe/Amsterdam
Leverkusen, August 17, 2018 - In reports appearing in its August 17 edition, and in an advance version on August 16, German magazine WirtschaftsWoche states that farmers in Arkansas and South Dakota have filed new class-action lawsuits over Dicamba i...
Read more
August
16,
2018
| 14:15 PM Europe/Amsterdam
Legal remedies against jury verdict in California announced...
Read more
August
01,
2018
| 13:00 PM Europe/Amsterdam
New treatment regimen could offer patients with neovascular age-related macular degeneration (AMD) extended proactive dosing already in the first year, while delivering strong visual gains / Data from ALTAIR study demonstrate sustainability of new ap...
Read more
July
31,
2018
| 15:00 PM Europe/Amsterdam
Significant step to bolster LEO Pharma’s role as a leading global dermatology company with its goal of helping 125 million patients by 2025...
Read more
July
27,
2018
| 14:45 PM Europe/Amsterdam
Positive CHMP opinion based on data from the largest Phase III rivaroxaban study, COMPASS / Once approved, rivaroxaban will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for th...
Read more
June
19,
2018
| 19:13 PM Europe/Amsterdam
Issue of four tranches with maturities of 4 to 11½ years was more than four times oversubscribed...
Read more
June
19,
2018
| 08:00 AM Europe/Amsterdam
Successful international placement secures long-term financing of the Monsanto acquisition / Issue of eight tranches with maturities of three to 30 years was approximately three times oversubscribed...
Read more
June
07,
2018
| 15:00 PM Europe/Amsterdam
Leverkusen, June 7, 2018 - Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on the New York Stock Exchange, with Bayer now the sole owner of Monsanto Company. Monsanto sharehold...
Read more
June
04,
2018
| 08:00 AM Europe/Amsterdam
Largest acquisition in company history to double size of agriculture business / Leading innovation engine in agriculture with pro forma R&D investment of 2.4 billion euros in 2017 / Transaction anticipated to generate significant value / Bayer streng...
Read more
June
03,
2018
| 18:44 PM Europe/Amsterdam
Final equity measure associated with the acquisition / Stockholders can acquire 2 new shares for every 23 shares they hold for 81.00 euros per new share...
Read more